News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
605,346 Results
Type
Article (43473)
Company Profile (320)
Press Release (561552)
Multimedia
Podcasts (80)
Webinars (13)
Section
Business (168154)
Career Advice (2449)
Deals (30404)
Drug Delivery (108)
Drug Development (78915)
Employer Resources (148)
FDA (14513)
Job Trends (13035)
News (296879)
Policy (28637)
Tag
Academia (2683)
Academic (1)
Accelerated approval (9)
Adcomms (29)
Allergies (98)
Alliances (43143)
ALS (116)
Alzheimer's disease (1510)
Antibody-drug conjugate (ADC) (174)
Approvals (14494)
Artificial intelligence (312)
Autoimmune disease (34)
Automation (17)
Bankruptcy (327)
Best Places to Work (10686)
BIOSECURE Act (16)
Biosimilars (110)
Biotechnology (259)
Bladder cancer (97)
Brain cancer (37)
Breast cancer (370)
Cancer (2905)
Cardiovascular disease (232)
Career advice (2061)
Career pathing (32)
CAR-T (195)
CDC (28)
Cell therapy (521)
Cervical cancer (21)
Clinical research (64804)
Collaboration (1016)
Company closure (3)
Compensation (501)
Complete response letters (28)
COVID-19 (2603)
CRISPR (66)
C-suite (347)
Cystic fibrosis (115)
Data (3002)
Decentralized trials (2)
Denatured (16)
Depression (72)
Diabetes (346)
Diagnostics (5891)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (41)
Drug discovery (142)
Drug pricing (124)
Drug shortages (25)
Duchenne muscular dystrophy (129)
Earnings (62665)
Editorial (43)
Employer branding (20)
Employer resources (137)
Events (91407)
Executive appointments (880)
FDA (16101)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (914)
Gene editing (141)
Generative AI (24)
Gene therapy (409)
GLP-1 (816)
Government (4341)
Grass and pollen (5)
Guidances (177)
Healthcare (17297)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (172)
Immuno-oncology (8)
Indications (39)
Infectious disease (2780)
Inflammatory bowel disease (159)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (121)
Interviews (524)
IPO (14341)
IRA (49)
Job creations (2763)
Job search strategy (1685)
Kidney cancer (15)
Labor market (33)
Layoffs (490)
Leadership (25)
Legal (6094)
Liver cancer (80)
Lung cancer (417)
Lymphoma (204)
Machine learning (11)
Management (52)
Manufacturing (360)
MASH (98)
Medical device (11216)
Medtech (11220)
Mergers & acquisitions (16743)
Metabolic disorders (870)
Multiple sclerosis (97)
NASH (23)
Neurodegenerative disease (128)
Neuropsychiatric disorders (41)
Neuroscience (2225)
NextGen: Class of 2025 (5977)
Non-profit (4132)
Now hiring (42)
Obesity (433)
Opinion (249)
Ovarian cancer (101)
Pain (109)
Pancreatic cancer (119)
Parkinson's disease (193)
Partnered (21)
Patents (294)
Patient recruitment (161)
Peanut (52)
People (54716)
Pharmaceutical (55)
Pharmacy benefit managers (16)
Phase I (20356)
Phase II (28626)
Phase III (21300)
Pipeline (1626)
Policy (200)
Postmarket research (2391)
Preclinical (8638)
Press Release (60)
Prostate cancer (141)
Psychedelics (44)
Radiopharmaceuticals (267)
Rare diseases (498)
Real estate (4514)
Recruiting (61)
Regulatory (20693)
Reports (29)
Research institute (2286)
Resumes & cover letters (360)
Rett syndrome (10)
RNA editing (10)
RSV (46)
Schizophrenia (94)
Series A (157)
Series B (110)
Service/supplier (3)
Sickle cell disease (64)
Special edition (16)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3197)
State (2)
Stomach cancer (15)
Supply chain (67)
Tariffs (48)
The Weekly (63)
Vaccines (760)
Venture capital (53)
Weight loss (275)
Women's health (38)
Worklife (17)
Date
Today (66)
Last 7 days (355)
Last 30 days (1794)
Last 365 days (29938)
2025 (16068)
2024 (33639)
2023 (37508)
2022 (48422)
2021 (52034)
2020 (50022)
2019 (42561)
2018 (32081)
2017 (29666)
2016 (28197)
2015 (32982)
2014 (25392)
2013 (20587)
2012 (21791)
2011 (22691)
2010 (20433)
Location
Africa (744)
Alabama (65)
Alaska (4)
Arizona (180)
Arkansas (12)
Asia (36819)
Australia (7277)
California (6940)
Canada (2272)
China (662)
Colorado (300)
Connecticut (280)
Delaware (190)
Europe (82647)
Florida (1042)
Georgia (225)
Hawaii (1)
Idaho (57)
Illinois (587)
India (25)
Indiana (318)
Iowa (14)
Japan (225)
Kansas (98)
Kentucky (26)
Louisiana (14)
Maine (53)
Maryland (967)
Massachusetts (5160)
Michigan (229)
Minnesota (396)
Mississippi (3)
Missouri (86)
Montana (24)
Nebraska (22)
Nevada (73)
New Hampshire (68)
New Jersey (1986)
New Mexico (25)
New York (1951)
North Carolina (1026)
North Dakota (7)
Northern California (3005)
Ohio (207)
Oklahoma (12)
Oregon (33)
Pennsylvania (1464)
Puerto Rico (17)
Rhode Island (33)
South America (1017)
South Carolina (31)
South Dakota (1)
Southern California (2659)
Tennessee (111)
Texas (1038)
United States (25618)
Utah (212)
Virginia (168)
Washington D.C. (65)
Washington State (597)
West Virginia (4)
Wisconsin (62)
605,346 Results for "akashi therapeutics formerly known as dart therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
June 4, 2025
·
4 min read
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics, formerly Freeline Therapeutics, today announced a new name and brand to reflect its focus on developing a new generation of gene therapies and advancing the practice of genetic medicine.
June 17, 2024
·
5 min read
Press Releases
NeuroEM Therapeutics(R) Closes Initial Rounds in $5 Million Equity Raise to Commercialize Drug-free Alzheimer’s Treatment
June 16, 2025
·
4 min read
Press Releases
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
June 3, 2025
·
4 min read
Press Releases
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
July 8, 2025
·
6 min read
Press Releases
Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress
May 12, 2025
·
7 min read
BioMidwest
Dermatology Association of Radiation Therapy (DART) Opposes Move to Cancel Medicare Coverage for Nonsurgical Treatment of Nonmelanoma Skin Cancer in Seven States
The Dermatology Association of Radiation Therapy (DART) filed comments in opposition to a proposed change in Medicare coverage in seven states of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for the treatment of nonmelanoma skin cancer (NMSC).
April 29, 2024
·
5 min read
Press Releases
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
May 28, 2025
·
4 min read
Press Releases
Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference
July 11, 2025
·
6 min read
1 of 60,535
Next
